| Nasopharyngeal Squamous Cell Carcinoma studied in …STUDIED_INderived10 of 43show all (up to 200) |
|---|
| → studied in | NCT05245682early Phase 1 · active not recruiting Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer · condition mapped CURATED_BROADER · 43 trials mapped (11 active) | — | — | Nasopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00336063Phase 1 · active not recruiting Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma · condition mapped CURATED_BROADER · 43 trials mapped (11 active) | — | — | Nasopharyngeal Keratinizing Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06532279Phase 2 · recruiting Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 43 trials mapped (11 active) | — | — | Nasopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03803774Phase 1 · active not recruiting Birinapant and Intensity Modulated Re-Irradiation Therapy in Treating Patients With Locally Recurrent Head and Neck Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 43 trials mapped (11 active) | — | — | Nasopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05063552Phase 2/Phase 3 · active not recruiting Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers · condition mapped CURATED_BROADER · 43 trials mapped (11 active) | — | — | Nasopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06662058NA · recruiting Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation · condition mapped CURATED_BROADER · 43 trials mapped (11 active) | — | — | Nasopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 43 trials mapped (11 active) | — | — | Nasopharyngeal Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06868433Phase 1 · recruiting TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer · condition mapped CURATED_BROADER · 43 trials mapped (11 active) | — | — | Nasopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06636734Phase 2 · recruiting Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial · condition mapped CURATED_BROADER · 43 trials mapped (11 active) | — | — | Nasopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02065362Phase 1 · active not recruiting TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPC · condition mapped ALIAS · 43 trials mapped (11 active) | — | — | EBV-Related Nasopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |